Lawrence E. Crane

Array ( [id] => 9245058 [patent_doc_number] => 08609339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'System and method for emulsion breaking and recovery of biological elements' [patent_app_type] => utility [patent_app_number] => 12/879493 [patent_app_country] => US [patent_app_date] => 2010-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10118 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12879493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9937422 [patent_doc_number] => 08987228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis' [patent_app_type] => utility [patent_app_number] => 13/394373 [patent_app_country] => US [patent_app_date] => 2010-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3677 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102600 [patent_doc_number] => 20110166093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'USE OF ADENOSINE RECEPTOR AGONISTS IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/875035 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166093.pdf [firstpage_image] =>[orig_patent_app_number] => 12875035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759835 [patent_doc_number] => 08420354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Methods to manufacture 1,3-dioxolane nucleosides' [patent_app_type] => utility [patent_app_number] => 12/870319 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 24285 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12870319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301947 [patent_doc_number] => 20120184505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'MODULATORS OF CELL CYCLE CHECKPOINTS AND THEIR USE IN COMBINATION WITH CHECKPOINT KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/393571 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24307 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959678 [patent_doc_number] => 20110184065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'USE OF SPONGOSINE FOR THE TREATMENT OF PAIN' [patent_app_type] => utility [patent_app_number] => 12/859932 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2749 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20110184065.pdf [firstpage_image] =>[orig_patent_app_number] => 12859932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10573095 [patent_doc_number] => 09295717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-29 [patent_title] => 'Vaccine composition comprising 5′-cap modified RNA' [patent_app_type] => utility [patent_app_number] => 13/388560 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 26252 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465874 [patent_doc_number] => 20120271043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'PROCESS AND DEVICE FOR COLLECTING NUCLEIC ACIDS OF MICROORGANISMS FROM A PARTICULATE SAMPLE' [patent_app_type] => utility [patent_app_number] => 13/387933 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4979 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064931 [patent_doc_number] => 20110201799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Synthesis of oligonucleotides' [patent_app_type] => utility [patent_app_number] => 12/839078 [patent_app_country] => US [patent_app_date] => 2010-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3975 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201799.pdf [firstpage_image] =>[orig_patent_app_number] => 12839078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6203123 [patent_doc_number] => 20110065909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'SYNTHESIS OF OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 12/836062 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5662 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065909.pdf [firstpage_image] =>[orig_patent_app_number] => 12836062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265853 [patent_doc_number] => 20120165285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'COMBINED PREPARATION FOR USE AS A MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 13/382885 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9112 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138501 [patent_doc_number] => 20120093795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'COMPOUNDS TARGETING THE CATION-INDEPENDENT MANNOSE 6-PHOSPHATE RECEPTOR' [patent_app_type] => utility [patent_app_number] => 13/380199 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11629 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093795.pdf [firstpage_image] =>[orig_patent_app_number] => 13380199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8160166 [patent_doc_number] => 20120101057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'COMBINED THERAPY OF COLORECTAL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 13/375653 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6150 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20120101057.pdf [firstpage_image] =>[orig_patent_app_number] => 13375653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6644271 [patent_doc_number] => 20100227831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'COMPOSITIONS AND METHODS FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/782774 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9296 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227831.pdf [firstpage_image] =>[orig_patent_app_number] => 12782774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6268259 [patent_doc_number] => 20100298530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Photoresponsive Base Having Triazole Skeleton' [patent_app_type] => utility [patent_app_number] => 12/780735 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11734 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298530.pdf [firstpage_image] =>[orig_patent_app_number] => 12780735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417528 [patent_doc_number] => 20120245029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS' [patent_app_type] => utility [patent_app_number] => 13/514007 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 26746 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6450549 [patent_doc_number] => 20100280233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'METHOD FOR SAMPLE PREPARATION' [patent_app_type] => utility [patent_app_number] => 12/773598 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7628 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280233.pdf [firstpage_image] =>[orig_patent_app_number] => 12773598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875834 [patent_doc_number] => 08470800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Method of reducing intraocular pressure in humans' [patent_app_type] => utility [patent_app_number] => 12/771289 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13258 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12771289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7741120 [patent_doc_number] => 08106183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Process for preparing an A2A-adenosine receptor agonist and its polymorphs' [patent_app_type] => utility [patent_app_number] => 12/765623 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6482 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106183.pdf [firstpage_image] =>[orig_patent_app_number] => 12765623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6516682 [patent_doc_number] => 20100261666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYOCARDIAL DYSFUNCTION ASSOCIATED WITH SIRS OR SEPSIS' [patent_app_type] => utility [patent_app_number] => 12/760381 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11753 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261666.pdf [firstpage_image] =>[orig_patent_app_number] => 12760381 [rel_patent_id] =>[rel_patent_doc_number] =>)